← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Dexamethason currently has availability issues reported in 2 European registers: Germany, Sweden.
Shortage ATC H02AB02 · also listed as: Dexamethason · dexametasonnatriumfosfat · data refreshed 13 September 2026
As of 13 September 2026, 2 of the 9 tracked registers list current availability issues for Dexamethason, covering 4 affected product presentations. The longest-running open report was filed in Sweden on 2026-05-25 and has now been open for about 4 months. The furthest expected-resolution date currently on file is 2027-01-29; the earliest is 2026-10-01. Momentum is current, not historical: 2 of the open reports were filed within the last 90 days. Registers in Germany, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Dexamethason is coded H02AB02 — a medicine acting on systemic hormonal preparations — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇩🇪 Germany | Shortage Dexamethason 1,5 mg Jenapharm | 2026-06-01 | 2027-01-29 | Sonstige Alternatives: N/A | register ↗ |
| 🇸🇪 Sweden | Shortage Dexacur 4 mg/ml Injektions-/infusionsvätska, lösning + 2 more productsDexafree 1 mg/ml Ögondroppar, lösning i endosbehållare Dexalcex 4 mg/ml Injektions-/infusionsvätska, lösning | 2026-05-25 | 2026-10-23 | — Alternatives: Alternative(s) available — see the national register. | register ↗ |
Every individual register entry for Dexamethason in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇸🇪 SE | Dexafree 1 mg/ml Ögondroppar, lösning i endosbehållare | Expected shortage | 2026-08-17 | 2026-10-01 | |
| 🇸🇪 SE | Dexacur 4 mg/ml Injektions-/infusionsvätska, lösning | Shortage | 2026-07-01 | 2026-10-15 | |
| 🇩🇪 DE | Dexamethason 1,5 mg Jenapharm | Shortage | 2026-06-01 | 2027-01-29 | Sonstige |
| 🇸🇪 SE | Dexalcex 4 mg/ml Injektions-/infusionsvätska, lösning | Shortage | 2026-05-25 | 2026-10-23 |
Yes. As of 13 September 2026, availability issues are reported in: Germany, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-10-01 to 2027-01-29. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
4 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Dexamethason: BfArM (Germany), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Dexamethason — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/dexamethason/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Dexamethason availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/dexamethason/">Dexamethason shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>